Today we welcome Mark Ogunsusi, PharmD, Esq. and  William H. von Oehsen, Esq. with Powers Pyles Sutter and Verville PC. Mark and Bill give insights to their conference talk unpacking Critical Policies, Arguments, and Expectations regarding Section 340B of the Public Health Service Act. Enacted in 1992, Section 340B entitles certain safety-net providers to purchase from manufacturers outpatient drugs at a deeply discounted ceiling price defined by the 340B statute. Drug manufacturers agree to provide the 340B discount in exchange for their drugs being reimbursed under the Medicaid and Medicare Part B programs – two important markets for most manufacturers. For nearly three decades, the safety net hospitals and clinics participating in the 340B program – referred to as “covered entities” in the statute -- have dispensed their 340B drugs through independent pharmacies operating under contract with covered entities. These contract pharmacy arrangements allow covered entities to extend the reach of their 340B pharmacy programs to more patients and are especially important for hospitals and clinics that lack their own in-house pharmacies. Finally, the presentation will discuss federal and state bills aimed at curbing the manufacturers’ restrictive policies, and key predictions for the future of 340B contract pharmacy arrangements. The 33rd annual American Society for Pharmacy Law Developments in Pharmacy Law seminar will be held November 3-6 at the Naples Grande Beach Resort in Naples, FL. The Seminar is being held in-person this year! Don't miss this opportunity to learn, share and network with seasoned legal and pharmaceutical professionals.  Attendees will have the opportunity to earn up to 15 hours of ACPE and CLE continuing education credits.  We look forward to having you join us in November!